Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT05352763

Public ClinicalTrials.gov record NCT05352763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension of the PTI-125-04 Study Evaluating the Safety and Long-Term Treatment of Simufilam in Mild-to-Moderate Alzheimer's Disease Patients

Study identification

NCT ID
NCT05352763
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cassava Sciences, Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Interventions

  • simufilam Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2022
Primary completion
Dec 30, 2024
Completion
Dec 30, 2024
Last update posted
Aug 14, 2025

2022 – 2024

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Cognitive Clinical Trials Gilbert Arizona 85296
Valley Research Center, Inc. Imperial California 92251
Brain Matters Research Delray Beach Florida 33445
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912
IMIC Research Palmetto Bay Florida 33157
Cognitive Clinical Trials Papillion Nebraska 68046
Advanced Memory Research Institute of NJ Toms River New Jersey 08755
the Ohio State University Columbus Ohio 43221
Senior Adults Specialty Research Austin Texas 78757

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05352763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2025 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05352763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →